Servizo
Oncoloxía médica
Publicacións (42) Publicacións nas que participase algún/ha investigador/a
2013
-
A 10-year step forward in hereditary cancer in Spain
Clinical and Translational Oncology
-
A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer
BMC Genomics, Vol. 14
-
Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial
Annals of Oncology, Vol. 24, Núm. 2, pp. 448-453
-
Adrenal carcinoma: A retrospective analysis of our series
Endocrinologia y Nutricion
-
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
PLoS ONE, Vol. 8, Núm. 7
-
Application of biotechnology in myocardial regeneration-tissue engineering triad: Cells, scaffolds, and signaling molecules
BioMed Research International
-
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer
Journal of Geriatric Oncology, Vol. 4, Núm. 2, pp. 114-121
-
Black-pigmented sputum
Journal of Cytology, Vol. 30, Núm. 4, pp. 274-275
-
C-terminal-PEDF reduces IC50 doses and chemoresistant population of CD133 and BCRP1-positve cancer stem like cells
Journal of Analytical Oncology, Vol. 2, Núm. 4, pp. 195-208
-
Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
PLoS ONE, Vol. 8, Núm. 1
-
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor
Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433
-
Consenso en cáncer hereditario entre la Sociedad Española de Oncología Médica y las sociedades de atención primaria
Semergen: revista española de medicina de familia, Núm. 5, pp. 259-266
-
Cáncer de pulmón en el área sanitaria de Pontevedra: incidencia, presentación clínica y supervivencia
Anales del sistema sanitario de Navarra, Vol. 36, Núm. 2, pp. 217-227
-
Dolor como factor predictor de depresión en el paciente oncológico: estudio de casos y controles. Estudio D-PRESS
Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 3, pp. 113-121
-
E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis
Oncogene, Vol. 32, Núm. 24, pp. 2937-2951
-
Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)
Clinical and Translational Oncology
-
FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer
Histopathology, Vol. 63, Núm. 2, pp. 174-186
-
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: Results from the GEICAM/2003-02 study
Journal of Clinical Oncology
-
Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: A retrospective study
Anticancer Research, Vol. 33, Núm. 9, pp. 4089-4096
-
Genetic study confirms association of HLA-DPA1*01:03 subtype with ankylosing spondylitis in HLA-B27-positive populations
Human Immunology, Vol. 74, Núm. 6, pp. 764-767